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Thank you, Dorothy; you warm the cockles of my
heart. John McEnroe once said,“The older you get, the
better you used to be,” and I feel a bit that way about
this award. When I think of all the things I could have
done, but didn’t, I wasn’t all that good. Nevertheless, I
thank the Awards Committee—and the Society—for this
honor, which, however undeserved, gives me great
pleasure.
My first experience in genetics education was trying
to explain to my parents why I wanted to study genetics,
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rather than medicine. Explaining wasn’t as easy then as
it would be now, and I did not do a good job; but they
supported me anyway, for which I thank them.
I spent a lot of my professional lifetime writing papers
for and lecturing to doctors about why genetics is im-
portant in medicine. We don’t have to do that any more;
the extraordinary advances in genetic knowledge have
made it obvious. But that doesn’t mean we can stop our
educational efforts. Our job is bigger than ever. We must
help physicians and paramedical workers learn how to
communicate with their patients about the enormous
amount of new information on genetic testing. We must
teach ourselves more efficient ways to organize genetic
services—and to gather, store, and convey genetic in-
formation—in the light of the increasing demand for
genetic counseling.
I want to talk briefly about a third obligation: to speak
out against a number of misconceptions that the public
have about the new genetics—some of them overly fear-
ful and some overly optimistic. One fear that gets a lot
of press time is that our new genetic-testing abilities will
lead to genetic discrimination. Some of us lament how
genetics is threatening peoples’ insurability and employ-
ability, without saying what to do about it. In fact, ge-
netic discrimination may not be that much of a problem
in clinical genetics (Billings 2000). Let’s start saying,
“Yes, we must be careful not to let this happen, but
people are working things out.” (One way to solve the
health insurance–discrimination problem, by the way, is
national health insurance. Try it, you’ll like it!) Some
so-called genetic discrimination isn’t genetic. I wrote a
letter to the editor in response to a story headlined “Ge-
netic Discrimination,” about a woman with A1AT de-
ficiency who was fired because her employer didn’t want
his company’s insurance plan to pay for her very ex-
pensive medication—which was genetic discrimination,
the author said. But the genetic revolution didn’t invent
A1AT deficiency. That it is genetic was irrelevant; it was
treatment discrimination. I know that nobody reads let-
ters to the editor, but at least one writer and one editor
may have learned something. So don’t hold back on your
letter writing.
Some of the fears that people have about the new
genetics stem from the idea that genetic interventions for
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preventing disorders or enhancement of normal traits
will alter the gene pool in unforeseen and disastrous
ways. Here are some of the gene-pool issues that are
raising hopes we must try to deflate—and concerns we
must strive to defuse:
The new genetics will allow us to cleanse our gene
pool by prenatal diagnosis (PND), to eradicate the bad
genes. This would clearly be a good thing but will have
eugenic implications and increase discrimination against
the disabled. The fear that PND will increase discrimi-
nation against the disabled is understandable, and we
must try hard to counteract such fears—but not by ban-
ning PND. Point out that our “preventive” interventions
affect only a small number of pregnancies. The Canadian
Royal Commission on New Reproductive Technologies
found that “genetic” abortions in 1990 constituted less
than 1% of all “therapeutic” abortions, and this number
is not likely to rise significantly, because of their highly
stressful nature. Preimplantation diagnosis (PID) is rare
and will never be widely used, as it involves the ineffi-
cient, stressful, and sometimes hazardous procedures of
in vitro fertilization. PND is too rare to make significant
changes in attitudes to the disabled, which are, in fact,
improving. Furthermore, most deleterious genes are not
exposed to selection, and mutation keeps adding them
to the gene pool, so selection against them would be
very inefficient. The gene pool is very stable. We will
never make it squeaky clean.
We will be able to use “designer genes” for enhance-
ment of normal traits—and pick and choose what kind
of babies we will have. This would lead to discrimina-
tion, change norms, and even alter human nature. Those
who had been enhanced might be issued with enhance-
ment certificates, which would be an advantage in the
job and marriage markets. The unenhanced might end
up being considered “disabled.”
There is little prospect that there will ever be signifi-
cant amounts of genetic enhancement, since “normal”
traits are very complex, and we are not likely to iden-
tify—much less manipulate—a significant number of
genes for intelligence, beauty, or whatever. Even if we
did, using PID to enhance a normal trait would involve
selecting embryos with several—say four—“superior”
genes. If each of these genes had a 50-50 chance of being
present, only 1 in 16 embryos would be suitable. Not
feasible! Furthermore, the use of PID is very limited, even
for severe disorders. Widespread PID is unimaginable. I
am not prepared to worry about how genetic interven-
tion will alter our gene pool and require us, as some
suggest, to reconsider the fundamental problem of dis-
tributive justice or decide whether it is permissible to
change human nature this way.
Gene therapy might be used to “cleanse the gene
pool,” cure our ills, and enhance our “normal” qualities,
with the same bad consequences as widespread PID. The
same counterarguments apply. In addition, there could
be unintended mutations, which could be passed on to
future generations “forever.” Point out that mutations
are happening all the time and that genetic interventions
that affect germ cells will not be numerous. It is unlikely
that created mutations would slip through the safe-
guards, but, if they did, they would not be passed on
forever. Dominant ones would be removed rapidly by
selection, and recessive ones would add insignificantly
to the large number already in our gene pool.
On the medical side, there is the idea that the new
genetics has transformed the practice of medicine. Well,
it certainly has, in terms of the increasing ability to di-
agnose diseases and even some predispositions. We will
have our hands full learning to cope with the increased
demands for service. So let’s not oversell ourselves. Here
are a few expectations we should try to deflate:
We will all be issued microchip genecards, listing hun-
dreds of loci and the ones at which we are mutant, so
we will be able to check out prospective mates to see
if they carry the same ones, choose which medications
to take if we have certain diseases, and see if we are
likely to develop a late-onset Mendelian disorder. Brave
new world? But for those of us who would not look
forward to this, don’t worry, it’s not likely to happen.
The genecard will never be cheap enough—or precise
enough—to be used for widespread screening, and there
is allelic heterogeneity (Cederbaum 2000). And think of
the confusion and (mis)apprehension that would be
caused by such screening without genetic-counseling
backup.
We will be able to define our genetic personality from
a drop of blood. Nonsense. The genetics of personality
is very messy, and the prospect of defining “personality
genes” is dim, if visible at all.
We will be able to screen healthy populations for hun-
dreds of susceptibility genes that increase risks for var-
ious common complex disorders and select against them
by PND or gene therapy; we could also identify which
environmental factors increase the expression of which
genes, so people could choose lifestyles that avoid spe-
cific environmental factors that increase the risk for their
particular genotype. Very nice, but it’s not so simple.
For one thing, the proportion of cases of a common
disease that can be attributed to susceptibility-conferring
genotypes is likely to be small. For a disorder with a
frequency of 1%—and susceptibility genes with a rela-
tive risk of 5%—the attributable risk would be about
4% under the most likely circumstances (Holtzman and
Marteau 2000). Secondly, susceptibility genes for com-
mon complex disorders are hard to find, since they have
low penetrance and increase risk only moderately. And
do we really want to get rid of these genes, even if we
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could? What keeps them in the population? They may
well be minor side effects of genes that have major ben-
eficial effects. To identify, in addition, which environ-
mental factors interact with which genotypes would be
an enormous task. And who wants to spend money
screening for genes with low penetrance and small ef-
fects? We can’t even decide what to do about “major”
susceptibility genes such as CF or hemochromatosis, for
goodness’ sake.
I don’t wish to detract from the immense value of the
work that’s going on in human molecular genetics,
which will bring us many benefits, but let’s not oversell
ourselves, as we did with gene therapy. We should all
be thinking of ways to clarify the public’s view of the
new genetics, allaying fears without inflating expecta-
tions. With this, I wish you success and bid you farewell.
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